Composition
- Active substance
- feline leukaemia virus recombinant canarypox virus (vCP97)
- International name (INN)
- vaccine against feline leukaemia
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Purevax FeLV
- Active substance
- feline leukaemia virus recombinant canarypox virus (vCP97)
- Group
- Veterinary medicines
- Status
- Authorised
- EMA product number
- EMEA/V/C/000056